Related Experiment Video
Updated: Aug 1, 2025
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Elimination of hepatitis C virus in a prison: An 18-year experience
Maite Nogales-Garcia1, Naiara Parraza Diez2, Andoni Vargas Axpe3
1Osakidetza Servicio Vasco de Salud, Centro de Salud Zaballa, Vitoria-Gasteiz, Spain; Osakidetza Servicio Vasco de Salud, Hospital Universitario Araba, Vitoria-Gasteiz, Spain.
Introduction:
Despite the decrease of hepatitis C in Spanish prisons in the last years, it still remains a reservoir for infection. The aim of this work is to analyze the characteristics of these patients and the response to antiviral treatment over the last 18 years.
Methods:
Retrospective observational study in inmates of Araba penitentiary center diagnosed with HCV infection between 2002 and 2020. A descriptive analysis of patient characteristics and the response to the three antiviral treatment modalities was performed: peg-interferon and ribavirin, peg-interferon, ribavirin and a first-generation protease inhibitor and different combinations of direct-acting antivirals.
Results:
A total of 248 antiviral treatments were prescribed. Treatment response rate up to 2015 was 65% and 93,7% after that year. Interferon non-responders were the main cause of non-response to treatment in periods 1 and 2 (40%-50%). Conversely, in period 3 viral breakthrough (67%) was the main culprit.
Conclusion:
After 18 years, active hepatitis C infection in prison inmates has resolved with treatment according to clinical criteria. Therefore, the stay in prison may represent an opportunity to reduce the reservoir of the disease in the community, together with continued health care for those released from prison.
